Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative life sciences businesses in the UK, Europe and the US. Advent Life Sciences and Harrington partnered in 2021 to launch the Advent-Harrington Impact Fund, a global investment fund to advance breakthrough discoveries into novel treatments. This initiative combines the best of Advent Life Sciences with the Harrington Discovery Institute pipeline. Download press release.
For more information on opportunities to work with Advent-Harrington, contact us.
To learn more about Advent Life Sciences, visit their website.